Lora Marden
Vice President, Patient Advocacy, Engagement & Innovation
Professional Overview
Lora Marden is an experienced healthcare executive with a strong focus on patient advocacy, engagement, and innovation. As the Vice President of Patient Advocacy, Engagement & Innovation at Cogent Biosciences, she is responsible for driving strategic initiatives that amplify the patient voice and optimize the patient experience across the organization.
Experience Summary
Current Role
In her role at Cogent Biosciences, Lora oversees the development and implementation of comprehensive patient-centric programs, ensuring that the company's product development and commercialization efforts are closely aligned with the needs and preferences of the patient community. She works closely with cross-functional teams to foster a culture of patient centricity, driving the integration of patient insights into all aspects of the business.
Career Progression
Prior to her current role, Lora served as the Executive Director and Head of Global Patient Advocacy & Engagement at Kiniksa Pharmaceuticals, where she was instrumental in establishing the company's patient advocacy function and building strong relationships with key patient organizations. She also held the position of Senior Director, Rare Disease Marketing at Sobi - North America, where she leveraged her expertise in patient engagement to drive strategic marketing initiatives for rare disease therapies.
Academic Background
Lora holds a Bachelor's degree from a prestigious university, where she specialized in biomedical sciences and public health. Her academic achievements and passion for patient-centered healthcare have been the foundation for her successful career in the biopharmaceutical industry.
Areas of Expertise
- Patient advocacy and engagement strategies
- Patient-centric product development and commercialization
- Rare disease and specialty therapy marketing
- Cross-functional collaboration and stakeholder management
- Strategic planning and program implementation
Professional Impact
Throughout her career, Lora has been recognized for her ability to amplify the patient voice and drive meaningful change within the healthcare ecosystem. She has led the development of innovative patient engagement initiatives that have improved patient outcomes and enhanced the overall patient experience. Lora's industry contributions and commitment to patient-centricity have earned her a reputation as a respected thought leader in the field of patient advocacy and engagement.
Conclusion
With over a decade of experience in the biopharmaceutical industry, Lora Marden is a seasoned professional who continues to drive positive change in the healthcare landscape. Her strategic vision, collaborative approach, and unwavering dedication to patients make her a valuable asset to Cogent Biosciences and the broader industry.
